December 03, 2021
1 min read
Save

FDA classifies intraoperative orthopedic strain sensors for class II assignment

The FDA has announced a final amendment to classify intraoperative orthopedic strain sensors into class II with special controls, which will allow for increased patient access to innovative implant strain devices, according to a release.

December 03, 2021
1 min read
Save

Roswell Park appoints chair in gynecologic oncology

Roswell Park appoints chair in gynecologic oncology

Emese Zsiros, MD, PhD, has been promoted to lead the department of gynecologic oncology at Roswell Park Comprehensive Cancer Center.

December 03, 2021
1 min read
Save

Initiative improves antibiotic prescribing for community-acquired pneumonia

Initiative improves antibiotic prescribing for community-acquired pneumonia

An initiative launched in dozens of Michigan hospitals more than doubled the rate of appropriate antibiotic prescribing for patients hospitalized with community-acquired pneumonia, researchers reported.

December 03, 2021
2 min read
Save

The Rome Foundation translates clinical diagnostic criteria

The Rome Foundation translates clinical diagnostic criteria

Modification of the Rome criteria into the new clinical practice model may reduce unnecessary diagnostics and enhances the patient-provider relationship, according to research published in Gastroenterology.

December 03, 2021
2 min read
Save

Ticagrelor-aspirin DAPT reduces risk for different types of MI

Ticagrelor-aspirin DAPT reduces risk for different types of MI

Ticagrelor added to low-dose aspirin reduced the risk for spontaneous MI, MI related to stent thrombosis and STEMI compared with placebo in patients with diabetes and CAD, according to a new analysis of the THEMIS trial.

December 03, 2021
1 min read
Save

FDA grants priority review to Reblozyl for beta-thalassemia subset

The FDA granted priority review to luspatercept-aamt for treatment of anemia among adults with non-transfusion-dependent beta-thalassemia.

December 03, 2021
1 min watch
Save

VIDEO: Susvimo provides predictable ranibizumab release, successful outcomes

VIDEO: Susvimo provides predictable ranibizumab release, successful outcomes

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Jay Stewart, MD, discusses his presentation on the Port Delivery System with ranibizumab, now called Susvimo (Genentech), including efficacy and safety study outcomes.

December 03, 2021
2 min read
Save

SGLT-2 inhibitors may prevent AKI in older adults with type 2 diabetes

SGLT-2 inhibitors may prevent AKI in older adults with type 2 diabetes

The initiation of SGLT-2 inhibitors correlated with a reduced risk of AKI in older adults with type 2 diabetes compared with other glucose-lowering medications.

December 03, 2021
2 min read
Save

Top news of November: Long COVID symptoms, virtual reality training, FeNO guidance and more

Top news of November: Long COVID symptoms, virtual reality training, FeNO guidance and more

The Healio Editors compiled the most-read news in pulmonology posted in November.

December 03, 2021
8 min read
Save

The ‘eharmony of immunotherapy’: Bispecific T-cell engagers vs. CAR-T for multiple myeloma

The ‘eharmony of immunotherapy’: Bispecific T-cell engagers vs. CAR-T for multiple myeloma

Bispecific T-cell engagers have induced impressive response rates among patients with relapsed or refractory multiple myeloma enrolled in early clinical trials.

Cardiology
Video
Save

Genetic Dyslipidemias: Familial Hypercholesterolemia and Beyond

This activity is supported by educational funding provided by Alexion Pharmaceuticals and Amryt Pharma DAC.

Genetic Dyslipidemias: Familial Hypercholesterolemia and Beyond
1.50
CME
1.50
ACPE
90
MINS
$0
FEE
Ophthalmology
Video
Save

Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment
0.75
CME
0.75
CME WITH ABO CONTINUING CERTIFICATION
45
MINS
$0
FEE
Ophthalmology
Video
Save

Curbside Consults: Severe Posterior Uveitis as a Spectrum of Disease

This activity is supported by an education grant from EyePoint Pharmaceuticals, Inc.

Faculty Photo
0.25
CME
0.25
CME WITH ABO CONTINUING CERTIFICATION
15
MINS
$0
FEE
Ophthalmology
Video
Save

Curbside Consults: Improving Long-term Post-Vitrectomy Outcomes With an Eye on Inflammation

This activity is supported by an education grant from EyePoint Pharmaceuticals, Inc.

Faculty Photo
0.25
CME
0.25
CME WITH ABO CONTINUING CERTIFICATION
15
MINS
$0
FEE
Ophthalmology
Video
Save

Curbside Consults: Achieving Sustained Reduction of Ocular Inflammation due to Noninfectious Uveitis

This activity is supported by an education grant from EyePoint Pharmaceuticals, Inc.

Faculty Photo
0.25
CME
0.25
CME WITH ABO CONTINUING CERTIFICATION
15
MINS
$0
FEE
Cardiology
Video
Save

Emergence of Novel Therapies for the Management of HFrEF

This activity is supported by an educational grant from Merck & Co., Inc.

Faculty Photo
1.00
CME
1.00
CNE
60
MINS
$0
FEE
Pediatrics
Video
Save

Pediatric Influenza: Advances in Vaccine Technology and Their Impact on Clinical Practice

This activity is supported by an educational grant from Seqirus USA Inc.

Pediatric Influenza: Advances in Vaccine Technology and their Impact on Clinical Practice
1.50
CME
1.50
CME WITH ABP MOC
90
MINS
$0
FEE
Ophthalmology
Video
Save

Real World Retina: Challenges in the Management of Retinal Diseases - Best of nAMD & RVO

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Faculty Photo
1.50
CME
1.50
CME WITH ABO CONTINUING CERTIFICATION
90
MINS
$0
FEE